Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II
- 1 March 2000
- journal article
- case report
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (3) , 774-777
- https://doi.org/10.1016/s0003-4975(99)01423-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Aortocoronary vein bypass in a patient with type II heparin-associated thrombopenia: A case reportInternational Journal of Angiology, 1998
- Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacementEuropean Journal of Cardio-Thoracic Surgery, 1997
- Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devicesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Beating Heart Implantation of a Wearable NOVACOR Left-Ventricular Assist DeviceThe Thoracic and Cardiovascular Surgeon, 1996
- Thromboembolism and bleeding: Clinical strategiesThe Annals of Thoracic Surgery, 1996
- A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1996
- Heparin-induced thrombocytopenia and heart operation: Management with tedelparinThe Annals of Thoracic Surgery, 1995
- “Heparin-free” Cardiopulmonary BypassAnesthesiology, 1990
- Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosisThe Annals of Thoracic Surgery, 1989
- THE USE OF ILOPROST(ZK36374) TO PERMIT CARDIOPULMONARY BYPASS IN 2 PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIAAnesthesiology, 1985